Methods of monitoring conditions by sequence analysis
US10246752B2 · kind B2 · utility
77Cited by
156References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 22, 2017 |
| Grant date | Apr 2, 2019 |
| Priority date | — |
| Expiry date | Nov 22, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A90/10
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
There is a need for improved methods for determining the diagnosis and prognosis of patients with conditions, including autoimmune disease and cancer. Provided herein are methods for using DNA sequencing to identify personalized biomarkers in patients with autoimmune disease and other conditions. Identified biomarkers can be used to determine the disease state for a subject with an autoimmune disease or other condition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.